Cathy C. Zhang

595 total citations
13 papers, 464 citations indexed

About

Cathy C. Zhang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cathy C. Zhang has authored 13 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cathy C. Zhang's work include Cancer Cells and Metastasis (6 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer-related Molecular Pathways (2 papers). Cathy C. Zhang is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Advanced Breast Cancer Therapies (2 papers) and Cancer-related Molecular Pathways (2 papers). Cathy C. Zhang collaborates with scholars based in United States and Hong Kong. Cathy C. Zhang's co-authors include Zhengming Yan, Cory L. Painter, James G. Christensen, Maruja E. Lira, Qin Zhang, Anthony Wong, Douglas D. Fang, Patrick B. Lappin, Peter Olson and Xiao Qi Wang and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Cathy C. Zhang

13 papers receiving 462 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cathy C. Zhang United States 11 288 196 91 61 52 13 464
Roi Villar-Vázquez Spain 6 263 0.9× 175 0.9× 99 1.1× 57 0.9× 63 1.2× 6 466
Eric C. Yang Canada 8 182 0.6× 132 0.7× 34 0.4× 50 0.8× 51 1.0× 14 411
Brieanne Midura United States 3 204 0.7× 205 1.0× 54 0.6× 38 0.6× 97 1.9× 4 401
F. Paulin United Kingdom 12 665 2.3× 182 0.9× 111 1.2× 42 0.7× 52 1.0× 14 826
Kian Kani United States 12 245 0.9× 177 0.9× 60 0.7× 87 1.4× 72 1.4× 21 438
Marilisa Cargnelutti Italy 9 270 0.9× 221 1.1× 132 1.5× 48 0.8× 100 1.9× 10 521
Mei‐Whey H. Wu United States 7 235 0.8× 142 0.7× 41 0.5× 37 0.6× 65 1.3× 8 352
John A. Curran United States 6 265 0.9× 169 0.9× 133 1.5× 18 0.3× 135 2.6× 15 486
Rob Noorlag Netherlands 14 261 0.9× 127 0.6× 118 1.3× 27 0.4× 47 0.9× 22 475
Carmelo Arizzi Italy 8 99 0.3× 145 0.7× 76 0.8× 43 0.7× 33 0.6× 8 292

Countries citing papers authored by Cathy C. Zhang

Since Specialization
Citations

This map shows the geographic impact of Cathy C. Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy C. Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy C. Zhang more than expected).

Fields of papers citing papers by Cathy C. Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy C. Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy C. Zhang. The network helps show where Cathy C. Zhang may publish in the future.

Co-authorship network of co-authors of Cathy C. Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy C. Zhang. A scholar is included among the top collaborators of Cathy C. Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy C. Zhang. Cathy C. Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Xia, Wei, et al.. (2018). Synergistic antitumor effect of a γ-secretase inhibitor PF-03084014 and sorafenib in hepatocellular carcinoma. Oncotarget. 9(79). 34996–35007. 22 indexed citations
2.
Xu, Ai‐Min, Cathy C. Zhang, Peter Olson, et al.. (2017). Notch Inhibitor PF-03084014 Inhibits Hepatocellular Carcinoma Growth and Metastasis via Suppression of Cancer Stemness due to Reduced Activation of Notch1–Stat3. Molecular Cancer Therapeutics. 16(8). 1531–1543. 60 indexed citations
3.
4.
Zhang, Cathy C., Zhengming Yan, Anand Giddabasappa, et al.. (2014). Comparison of dynamic contrast‐enhanced MR, ultrasound and optical imaging modalities to evaluate the antiangiogenic effect of PF‐03084014 and sunitinib. Cancer Medicine. 3(3). 462–471. 17 indexed citations
5.
Fang, Douglas D., Cathy C. Zhang, Yin Gu, et al.. (2013). Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation. PLoS ONE. 8(6). e67258–e67258. 33 indexed citations
6.
O’Brien, Peter J., Michelle Lee, Mary E. Spilker, et al.. (2013). Monitoring metabolic responses to chemotherapy in single cells and tumors using nanostructure-initiator mass spectrometry (NIMS) imaging. Cancer & Metabolism. 1(1). 4–4. 41 indexed citations
7.
Zhang, Cathy C., Zhengming Yan, Douglas D. Fang, et al.. (2013). Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models. Stem Cells Translational Medicine. 2(3). 233–242. 78 indexed citations
8.
Zhang, Cathy C., Adam Pavlı́c̀ek, Qin Zhang, et al.. (2012). Biomarker and Pharmacologic Evaluation of the γ-Secretase Inhibitor PF-03084014 in Breast Cancer Models. Clinical Cancer Research. 18(18). 5008–5019. 53 indexed citations
9.
Zhang, Cathy C., Zhengming Yan, Douglas D. Fang, et al.. (2012). Abstract 3492: γ-secretase inhibitor PF-03084014 diminishes the tumor-initiating cells and demonstrates synergy with docetaxel in breast cancer xenograft models. Cancer Research. 72(8_Supplement). 3492–3492. 1 indexed citations
10.
Zhang, Cathy C., Zhengming Yan, Wenlin Li, et al.. (2011). [18F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells. Clinical Cancer Research. 18(5). 1303–1312. 62 indexed citations
11.
Zhang, Cathy C., Zhengming Yan, Qin Zhang, et al.. (2010). PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity. Clinical Cancer Research. 16(21). 5177–5188. 58 indexed citations
12.
Zhang, Cathy C., Susan E. Kephart, Indrawan McAlpine, et al.. (2005). AG-024322 is a potent and selective multi-targeted CDK inhibitor with broad spectrum anti-proliferative activity. Cancer Research. 65. 1045–1045. 8 indexed citations
13.
Zhang, Cathy C., Theodore J. Boritzki, & Robert Jackson. (1997). An inhibitor of glycinamide ribonucleotide formyltransferase is selectively cytotoxic to cells that lack a functional G1 checkpoint. Cancer Chemotherapy and Pharmacology. 41(3). 223–228. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roi Villar-Vázquez Breakdown of academic impact, for papers by Eric C. Yang Breakdown of academic impact, for papers by Brieanne Midura Breakdown of academic impact, for papers by F. Paulin Breakdown of academic impact, for papers by Kian Kani Breakdown of academic impact, for papers by Marilisa Cargnelutti Breakdown of academic impact, for papers by Mei‐Whey H. Wu Breakdown of academic impact, for papers by John A. Curran Breakdown of academic impact, for papers by Rob Noorlag Breakdown of academic impact, for papers by Carmelo Arizzi
Rankless by CCL
2026